Aastrom Biosciences Announces Stem Cell Results
ANN ARBOR, Mich., Apr 17, 2008 (PrimeNewswire via COMTEX News Network) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced encouraging data from the first two compassionate use patients treated with the Company’s autologous stem cell therapy for dilated cardiomyopathy (DCM), a type of severe chronic heart failure. Hans Michael Klein, M.D., [.. more ..]
Filed under: High Tech | No Comments »